A case of nivolumab-induced cervical lymphadenopathy in a patient with gastric cancer

Nivolumab is a monoclonal antibody targeting programmed cell death-1 (PD-1) that has been recently shown to exhibit clinical efficacy in patients with gastric cancer. However, various degrees of immune-related adverse events (irAEs) have been reported. We report the case of a 71-year-old male patien...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Gastrointest Oncol
Huvudupphovsmän: Taira, Koichi, Kimura, Akie, Nakata, Akinobu, Nadatani, Yuji, Fukunaga, Shusei, Otani, Koji, Hosomi, Shuhei, Tanaka, Fumio, Kamata, Noriko, Nagami, Yasuaki, Watanabe, Toshio, Fujiwara, Yasuhiro
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2021
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107580/
https://ncbi.nlm.nih.gov/pubmed/34012675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-315
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk